Equipment Selection and Techniques of Percutaneous Coronary Intervention
When Gruentzig first developed balloon angioplasty in the late 1970s, generally only patients with proximal discrete single-vessel lesions could be approached . As angioplasty techniques, equipment, operator experience, and adjunctive therapies improved over the years, the scope of angioplasty extended to acute coronary syndromes, multivessel disease, and higher risk categories of patients. For each patient, the question posed must be whether relief of a single stenosis or multiple stenoses is possible and desirable, and whether complete revascularization is achievable. New technology has evolved, and many new devices have been used to treat specific types of lesions. Current devices used in catheterization laboratories include directional, extraction, and rotational atherectomy, stenting (now the most predominant treatment), lasers, and filters. Use of guide catheters, wires, and balloons is necessary, and common to most devices reviewed in this chapter.
Gruentzig AR: Transluminal dilatation of coronary artery stenosis [letter]. Lancet
1978, II:263.CrossRefGoogle Scholar
Arani DT: A new catheter for angioplasty of the right coronary artery and aorto-coronary bypass graft. Cathet Cardiovasc Diagn
1985, 11:647–653.PubMedCrossRefGoogle Scholar
Metz D, Meyer P, Elaerts J: Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: results of a prospective, multicen-ter, randomized trial. Am Heart J
1997, 134:131–137.PubMedCrossRefGoogle Scholar
Simpson JB, Bairn DS, Robert EW, et al
.: A new catheter system for angioplasty. Am J Cardiol
1982, 49:1216–1222.PubMedCrossRefGoogle Scholar
Talley JD, Hurst JW, King SB, et al.
: Clinical outcome five years after attempted percutaneous transluminal coronary angioplasty in 427 patients. Circulation
1988, 77:820–829.PubMedCrossRefGoogle Scholar
King SB III: Angioplasty from bench to bedside. Circulation
1996, 93:1621–1629.PubMedCrossRefGoogle Scholar
Bonzel T, Wollschlager H, Meinertz T, et al.
: The steerable monorail catheter system: a new device for PTCA [abstract]. Circulation
1986, 74(suppl):II-459.Google Scholar
Bonzel T, Wollschlager H, Kasper W, et al.
: The sliding rail system (monorail): description of a new technique for intravascular instrumentation and its application to coronary angioplasty. Z Kardiol
1987, 76(suppl 6):119–122.PubMedGoogle Scholar
Stack RS, Quigley PJ, Collins G, et al.
: Perfusion balloon catheter. Am J Cardiol
1988, 61:776–806.CrossRefGoogle Scholar
Tepel M, van der Giet M, Zikek W: Prevention of radiographic contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med
Seldinger SI: Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol Scand
1953, 39:368.CrossRefGoogle Scholar
Chew DP, Bhatt DL, Topol EJ: Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from six randomized, controlled trials. Circulation
2001, 103:961–966.PubMedCrossRefGoogle Scholar
Kaluski E, Krakover R, Vered Z: Minimal heparinization in coronary angioplasty—how much heparin is really warranted? Am J Cardiol
2000, 85:953–956.PubMedCrossRefGoogle Scholar
Koch KT, Piek JJ, Lie KI: Safety of low-dose heparin in elective coronary angioplasty Heart
1997, 778:517–522.Google Scholar
O’Shea JC, Hafley GE, Tcheng JE: Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA
2001, 285:2468–2473.PubMedCrossRefGoogle Scholar
The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med
1994, 330:956–961.CrossRefGoogle Scholar
© Springer Science+Business Media New York 2003